Anti-viral therapy for Covid (as of 1/5/22)

 1) Sotrovimab IV (GSK) - Monoclonal antibodies - reduces hospitalization by 90%, effective against Omicron variant.

2) Oral Paxlovid (Nirmatlevir/Ritonavir, Pfizer)  - x 5 days - reduces hospitalization by 90%.

3) Remdesvir IV (Gilead) - x 3 days - reduces hospitalization by 90%.

4) Oral Molnupiravir (Merck) - x 5 days - reduces hospitalization by 30%.